We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Image Analysis Software Reliably Identifies Positive MRSA

By LabMedica International staff writers
Posted on 24 Feb 2016
In a unique-in-its-class digital microbiology study of almost 60,000 samples, new WASPLab software developed for automated colony-scoring of chromegenic media plates provided superior detection of methicillin-resistant Staphylococcus aureus (MRSA).

The groundbreaking results came from an international multicenter study, testing 57,690 samples, where the WASPLab platform software “Chromogenic Detection Module” (CDM) from COPAN Diagnostics, Inc. More...
(Murrieta, CA, USA) detected and segregated positive from negative MRSA samples using chromogenic agar with a sensitivity of 100% and a specificity of 90%–96% (varying by location). The software detected an additional 153 positive MRSA patients that were missed by manual reading.

The study's sample size and level of sensitivity of 100% “makes this study unmatched in the industry," said Norman Sharples, CEO, Copan Diagnostics.

CDM utilizes an algorithm to identify presence of colonies on a plate and distinguish between different colors to group into negative and positive cultures. The study focused on identifying MRSA using chromogenic agar from 3 different manufacturers (BD Diagnostics, bioMeriéux, Bio-Rad Laboratories) that produce growth with different pigmentation colors. The cultures were read automatically by WASPLab CDM and manually by a laboratory professional. The laboratory professionals were blinded to the software's results.

CDM's reading threshold is intentionally set with a high level of prudency designed so it does not miss a positive MRSA culture. In fact, in this large study, CDM never reported any manual positive plates as negative, demonstrating 100% sensitivity. The 90%–96% specificity score varies by location due to the conservative threshold of the CDM settings, which set the limitations low in order to avoid any "false negative" interpretation. Most importantly, the data from this study suggests that the CDM software is somewhat more sensitive than manual reading of plate cultures.

The software’s “capability reduces the hands-on time considerably,” said Dr. Sharples, “CDM is not meant to be used without the technologist, but to provide the technologist with valuable tools that rapidly pre-screen cultures, detect the presence of specific organisms of interest or known pathogens, then segregate cultures into positive and negative groups that enable faster turnaround times and actionable results within the therapeutic window."

The results of the data show that the WASPLab CDM can be used to accurately sort regardless of the chromogenic substrate. Its application for MRSA is only the first step in a series of algorithms developed by COPAN and available to WASPLab users to further the relevance and speed of laboratory results.

"Clinical microbiology relies heavily on the reading and interpretational skills of the technologist and microbiologist. In a time of diminishing resources and increasing work volumes the advancement in these imaging algorithms supports the value of digital microbiology and full laboratory automation for the continued output of quality results and improved patient care," concluded Dr. Sharples.

The study, by Faron ML et al., was published online ahead of print December 30, 2015, in the Journal of Clinical Microbiology.

Related Links:

COPAN Group



New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.